Saltar al contenido
Merck

Clinical application and quantitative evaluation of generator-produced copper-62-PTSM as a brain perfusion tracer for PET.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine (1994-12-01)
H Okazawa, Y Yonekura, Y Fujibayashi, S Nishizawa, Y Magata, K Ishizu, F Tanaka, T Tsuchida, N Tamaki, J Konishi
RESUMEN

Copper-62-pyruvaldehyde bis(N4-methylthiosemicarbazone) copper II (62Cu-PTSM) has been proposed as a generator-produced positron-emitting tracer for perfusion imaging. To evaluate the characteristics of 62Cu-PTSM as a cerebral perfusion tracer, brain PET images of 62Cu-PTSM were compared with cerebral blood flow (CBF). Following an intravenous injection of 62Cu-PTSM, a serial dynamic PET scan was performed for 10 min with arterial sampling in 10 subjects. CBF was measured by 15O-labeled water before the 62Cu-PTSM study. Dynamic PET scan with octanol-extracted arterial input function indicated the presence of significant back-diffusion of 62Cu-PTSM from the brain within 3 min after injection, followed by stable activity from 3 to 10 min. Comparison with 15O-water PET demonstrated less contrast between high- and low-flow regions in 62Cu-PTSM image and a nonlinear relationship of flow and 62Cu-PTSM uptake, which suggests the underestimation of CBF in high-flow regions due to the existence of back-diffusion. Although 62Cu-PTSM can be used widely for evaluation of brain perfusion with PET, kinetic analysis and correction may be needed to quantify regional CBF.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
1-Octanol, suitable for HPLC, ≥99%
Sigma-Aldrich
1-Octanol, ReagentPlus®, 99%
Sigma-Aldrich
1-Octanol, anhydrous, ≥99%
Sigma-Aldrich
1-Octanol, ≥98%, FCC, FG
Supelco
1-Octanol, analytical standard
Sigma-Aldrich
1-Octanol, natural, ≥98%, FCC